Cargando…

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer

Neoadjuvant chemotherapy (NAC) is used to treat triple-negative breast cancer (TNBC) prior to resection. Biomarkers that accurately predict a patient’s response to NAC are needed to individualise therapy and avoid chemotoxicity from unnecessary chemotherapy. We performed whole-genome DNA methylation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meyer, Braydon, Clifton, Samuel, Locke, Warwick, Luu, Phuc-Loi, Du, Qian, Lam, Dilys, Armstrong, Nicola J., Kumar, Beena, Deng, Niantao, Harvey, Kate, Swarbrick, Alex, Ganju, Vinod, Clark, Susan J., Pidsley, Ruth, Stirzaker, Clare
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684655/ https://www.ncbi.nlm.nih.gov/pubmed/34922619 http://dx.doi.org/10.1186/s13148-021-01210-6

Ejemplares similares

MethPanel: a parallel pipeline and interactive analysis tool for multiplex bisulphite PCR sequencing to assess DNA methylation biomarker panels for disease detection
por: Luu, Phuc-Loi, et al.
Publicado: (2020)

Advances in Prognostic Methylation Biomarkers for Prostate Cancer
por: Lam, Dilys, et al.
Publicado: (2020)

Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels
por: Lam, Dilys, et al.
Publicado: (2020)

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
por: Pidsley, Ruth, et al.
Publicado: (2022)

Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA
por: Skvortsova, Ksenia, et al.
Publicado: (2017)

DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients
por: Mathe, Andrea, et al.
Publicado: (2016)

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer
por: Stone, Andrew, et al.
Publicado: (2015)

Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models
por: Deng, Niantao, et al.
Publicado: (2022)

Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer
por: Du, Qian, et al.
Publicado: (2019)

Benchmark study comparing liftover tools for genome conversion of epigenome sequencing data
por: Luu, Phuc-Loi, et al.
Publicado: (2020)

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
por: Achinger-Kawecka, Joanna, et al.
Publicado: (2020)

Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis
por: Locke, Warwick J, et al.
Publicado: (2015)

Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer
por: Alamgeer, Muhammad, et al.
Publicado: (2014)

Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling
por: Pidsley, Ruth, et al.
Publicado: (2016)

Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
por: Khoury, Amanda, et al.
Publicado: (2020)

Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC
por: Brockwell, Natasha K., et al.
Publicado: (2019)

Disclosing the crosstalk among DNA methylation, transcription factors, and histone marks in human pluripotent cells through discovery of DNA methylation motifs
por: Luu, Phuc-Loi, et al.
Publicado: (2013)

Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis
por: Locke, Warwick J, et al.
Publicado: (2012)

Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer
por: Lawrence, Mitchell G., et al.
Publicado: (2020)

Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements
por: Peters, Timothy J, et al.
Publicado: (2019)

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
por: Cazet, Aurélie S., et al.
Publicado: (2018)

Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials
por: Amos, Keith D., et al.
Publicado: (2012)

Controversial issues in the neoadjuvant treatment of triple-negative breast cancer
por: Fitzpatrick, Amanda, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
por: Shao, Zhiying, et al.
Publicado: (2016)

Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023)

The DNA methylation landscape in cancer
por: Skvortsova, Ksenia, et al.
Publicado: (2019)

The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer
por: Castrellon, Aurelio Bartolome, et al.
Publicado: (2017)

Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
por: Lee, Jin Sun, et al.
Publicado: (2020)

Immune responses during neoadjuvant chemotherapy in triple negative breast cancer
por: Ghallab, Ahmed
Publicado: (2020)

Therapeutic pattern and progress of neoadjuvant treatment for triple-negative breast cancer
por: Xiao, Yan, et al.
Publicado: (2022)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

Evolving Evidence for the Optimization of Neoadjuvant Therapy in Triple-Negative Breast Cancer
por: Silva, Diogo, et al.
Publicado: (2022)

The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Johnson, Kai Conrad Cecil, et al.
Publicado: (2023)

Epigenetic Therapies and Biomarkers in Breast Cancer
por: Brown, Lauren Julia, et al.
Publicado: (2022)

Multiplex bisulfite PCR resequencing of clinical FFPE DNA
por: Korbie, Darren, et al.
Publicado: (2015)

Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
por: Goel, Arun Kumar, et al.
Publicado: (2010)

Neoadjuvant Therapy in Operable Breast Cancer: Application to Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2013)

BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Tanino, Hirokazu, et al.
Publicado: (2016)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016)

Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jung, Yoon Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k6hge775p65vse074t01p4hf39